Editorial Comment from Dr Murtola to Reduction of prostate cancer incidence by naftopidil, an α1-adrenoceptor antagonist and transforming growth factor-β signaling inhibitor

    Research output: Contribution to journalComment/debateScientific

    Original languageEnglish
    Pages (from-to)1227-1228
    JournalINTERNATIONAL JOURNAL OF UROLOGY
    Volume20
    Issue number12
    DOIs
    Publication statusPublished - 2013
    Publication typeB1 Article in a scientific magazine

    Cite this